| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tempest Therapeutics, Inc. (TPST) has 5 insiders with recent SEC Form 4 filings, including 9 buys and 2 sells. TPST is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.6K | $536.5K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - | |
| Dir | 1.2K | $2.4K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | Versant Venture Capital Vi, L.P.64 | 10% Owner | Sell | 787,999 | $1.23 | $967,032.90 | -49.4% | +14.9% | -29.2% | |
| Jul 3, 2024 | Brady Stephen R | President And CEO | Buy | 35,000 | $2.11 | $73,850.00 | +307.7% | -37.0% | -74.0% | |
| Jul 2, 2024 | Whiting Samuel | Chief Medical Officer | Buy | 4,672 | $2.13 | $9,951.36 | +95.3% | -34.0% | -74.1% | |
| Jun 28, 2024 | Trojanowski Justin | Corporate Controller | Buy | 7,500 | $2.16 | $16,200.00 | +51.1% | -40.6% | -75.8% | |
| Apr 29, 2022 | Woiwode Thomas | Director, 10% Owner | Buy | 2,118,644 | $2.36 | $4,999,999.84 | New | -41.3% | -41.3% | |
| Jan 7, 2022 | Dubensky Thomas W. | President | Buy | 2,000 | $4.78 | $9,560.00 | +1.8% | -19.1% | -71.5% | |
| Jan 6, 2022 | Whiting Samuel | Chief Medical Officer | Buy | 1,700 | $4.80 | $8,168.16 | +845.8% | -11.5% | -71.9% | |
| Jun 1, 2016 | Dipp Michelle | Chief Executive Officer | Buy | 425,000 | $7.00 | $2,975,000.00 | +79.1% | - | - | |
| Jun 1, 2016 | Aldrich Richard | Director | Buy | 425,000 | $7.00 | $2,975,000.00 | +79.1% | - | - | |
| May 18, 2016 | Aldrich Richard | Director | Buy | 20,000 | $7.86 | $157,200.00 | +3.9% | - | - |